AZTA
AZTA
US1143401024
Azenta, Inc.
Loading chart...

Company Profile

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Latest News

Related stocks

KMTS
KMTS • United States
Kestra Medical Technologies, Lt
26.98 USD
1.61B USD 1Y +7.4%
BLFS
BLFS • United States
BioLife Solutions, Inc.
38.61 USD
1.89B USD
PLSE
PLSE • United States
Pulse Biosciences, Inc
53.81 USD
3.84B USD 1Y +150.7%
STAA
STAA • United States
STAAR Surgical Company
21.67 USD
1.09B USD 1Y -15.5%
ATRC
ATRC • United States
AtriCure, Inc.
55.81 USD
2.84B USD 1Y +50.6%
XRAY
XRAY • United States
DENTSPLY SIRONA Inc.
8.83 USD
1.76B USD 1Y -29.8%
WRBY
WRBY • United States
Warby Parker Inc.
25.3 USD
3.13B USD 1Y +1.4%
MMED
MMED • United States
MiniMed Group, Inc.
19.71 USD
5.55B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
53.0% p.a.
Max Drawdown (5Y)
-87.1%
Sharpe Ratio (5Y)
-0.39
Beta Factor
1.52
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 1.52 indicates above-average volatility compared to the broader market.
🔴 High valuation risk: Avg P/E of 68.3 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (53.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -87.1% in the extended horizon.
ende